Evidence map›Paper›PMID 30011120›Full record

ReviewMolecular plant pathology2018

Molecular mechanisms that limit the costs of NLR-mediated resistance in plants.

Manon M S Richard, Ariane Gratias, Blake C Meyers, Valérie Geffroy

Open access · greenAbstract readReview
In one paragraph

Review in Molecular plant pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Mechanisms and balanced regulation of plant immunity.Nature reviews. Molecular cell biology · 2026
    Review
  3. Review
  4. Review
  5. Precision Editing of NLRS Improves Effector Recognition for Enhanced Disease Resistance.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Simultaneous mutations inPlant signaling & behavior · 2022
    Article
  14. Engineering Resistance againstPlants (Basel, Switzerland) · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Manon M S RichardMolecular Plant Pathology, SILS, University of Amsterdam, PO Box 94215, 1090 GE, Amsterdam, the Netherlands.
Ariane GratiasInstitute of Plant Sciences Paris-Saclay IPS2, CNRS, INRA, Université Paris-Saclay, Université Paris-Sud, Université Evry, Université Paris-Diderot, Sorbonne Paris-Cité, Bâtiment 630, 91405, Orsay, France.
Blake C MeyersDonald Danforth Plant Science Center, 975 North Warson Road, St Louis, MO, 63132, USA.
Valérie GeffroyInstitute of Plant Sciences Paris-Saclay IPS2, CNRS, INRA, Université Paris-Saclay, Université Paris-Sud, Université Evry, Université Paris-Diderot, Sorbonne Paris-Cité, Bâtiment 630, 91405, Orsay, France.
Université Paris-Sud · FRDonald Danforth Plant Science Center · USGeneral Electric (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crop diseases cause significant yield losses, and the use of resistant cultivars can effectively mitigate these losses and control many plant diseases. Most plant resistance (R) genes encode immune receptors composed of nucleotide-binding and leucine-rich repeat (NLR) domains. These proteins mediate the specific recognition of pathogen avirulence effectors to induce defence responses. However, NLR-triggered immunity can be associated with a reduction in growth and yield, so-called 'fitness costs'. Recent data have shown that plants use an elaborate interplay of different mechanisms to control NLR gene transcript levels, as well as NLR protein abundance and activity, to avoid the associated cost of resistance in the absence of a pathogen. In this review, we discuss the different levels of NLR regulation (transcriptional, post-transcriptional and at the protein level). We address the apparent need for plants to maintain diverse modes of regulation. A recent model suggesting an equilibrium 'ON/OFF state' of NLR proteins, in the absence of a pathogen, provides the context for our discussion.

Indexed as

Disease ResistanceGene Expression Regulation, PlantNLR ProteinsPlant ImmunityPlantsNLR Proteinscostmethylationplant disease resistance genespost-transcriptional regulationsmall RNAstranscriptional regulation

Identifiers

PMID30011120
PMCPMC6638094
OpenAlexW2884759309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.